Bacterial meningitis: insights into pathogenesis and evaluation of new treatment options: a perspective from experimental studies

被引:30
|
作者
Liechti, Fabian D. [1 ]
Grandgirard, Denis [1 ]
Leib, Stephen L. [1 ,2 ]
机构
[1] Univ Bern, Inst Infect Dis, Neuroinfect Lab, CH-3010 Bern, Switzerland
[2] Swiss Fed Off Civil Protect, Div Biol, Spiez Lab, CH-3700 Spiez, Switzerland
基金
瑞士国家科学基金会;
关键词
animal model; bacterial meningitis; brain injury; dentate gyrus; neurogenesis; neuroinfection; neuroinflammation; Streptococcus pneumoniae; NECROSIS-FACTOR-ALPHA; BLOOD-BRAIN-BARRIER; NONBACTERIOLYTIC ANTIBIOTIC DAPTOMYCIN; EXPERIMENTAL PNEUMOCOCCAL MENINGITIS; AGGRAVATES HIPPOCAMPAL APOPTOSIS; STAPHYLOCOCCUS-AUREUS MENINGITIS; INFLUENZAE TYPE-B; CEREBROSPINAL-FLUID; STREPTOCOCCUS-PNEUMONIAE; DENTATE GYRUS;
D O I
10.2217/fmb.15.43
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Bacterial meningitis is associated with high mortality and morbidity rates. Bacterial components induce an overshooting inflammatory reaction, eventually leading to brain damage. Pathological correlates of neurofunctional deficits include cortical necrosis, damage of the inner ear and hippocampal apoptosis. The hippocampal dentate gyrus is important for memory acquisition and harbors a neuronal stem cell niche, thus being potentially well equipped for regeneration. Adjuvant therapies aimed at decreasing the inflammatory reaction, for example, dexamethasone, and those protecting the brain from injury have been evaluated in animal models of the disease. They include nonbacteriolytic antibiotics (e.g., daptomycin), metalloproteinase inhibitors and modulators of the immunological response, for example, granulocyte colony-stimulating factor. Increasing research interest has recently been focused on interventions aimed at supporting regenerative processes.
引用
收藏
页码:1195 / 1213
页数:19
相关论文
共 50 条
  • [1] Bacterial meningitis: an update of new treatment options
    Nau, Roland
    Djukic, Marija
    Spreer, Annette
    Ribes, Sandra
    Eiffert, Helmut
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2015, 13 (11) : 1401 - 1423
  • [2] Bacterial meningitis: current therapy and possible future treatment options
    Woehrl, Bianca
    Klein, Matthias
    Grandgirard, Denis
    Koedel, Uwe
    Leib, Stephen
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2011, 9 (11) : 1053 - 1065
  • [3] Bacterial meningitis: new treatment options to reduce the risk of brain damage
    Principi, Nicola
    Esposito, Susanna
    EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (01) : 97 - 105
  • [4] The Role of Microglia in Bacterial Meningitis: Inflammatory Response, Experimental Models and New Neuroprotective Therapeutic Strategies
    Thorsdottir, Sigrun
    Henriques-Normark, Birgitta
    Iovino, Federico
    FRONTIERS IN MICROBIOLOGY, 2019, 10
  • [5] New advances in the pathogenesis and pathophysiology of bacterial meningitis
    Barnett R. Nathan
    W. Michael Scheld
    Current Infectious Disease Reports, 2000, 2 (4) : 332 - 336
  • [6] Role of circadian rhythms in pathogenesis of acute CNS injuries: Insights from experimental studies
    Hetman, Michal
    Slomnicki, Lukasz P.
    Hodges, Emily R.
    Ohri, Sujata Saraswat
    Whittemore, Scott R.
    EXPERIMENTAL NEUROLOGY, 2022, 353
  • [7] NEW TREATMENT STRATEGIES FOR BACTERIAL-MENINGITIS
    ROOS, KL
    CLINICAL NEUROPHARMACOLOGY, 1993, 16 (05) : 373 - 386
  • [8] Evaluation of a triple-drug combination for treatment of experimental multidrug-resistant pneumococcal meningitis
    Lee, H
    Song, JH
    Kim, SW
    Oh, WS
    Jung, SI
    Kiem, S
    Peck, KR
    Lee, NY
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2004, 23 (03) : 307 - 310
  • [9] New Insights in the Prevention, Diagnosis, and Treatment of Cryptococcal Meningitis
    Jackson, Arthur
    van der Horst, Charles
    CURRENT HIV/AIDS REPORTS, 2012, 9 (03) : 267 - 277
  • [10] What's new in the treatment of bacterial meningitis in childhood?
    Sarlangue, J.
    Castella, C.
    Lehours, P.
    ARCHIVES DE PEDIATRIE, 2009, 16 (06): : 787 - 789